Article 196 of Brazil's 1988 Constitution is the justiciable health clause the UDHR never wrote.
"Health is a right of all and a duty of the State, guaranteed through social and economic policies aimed at reducing the risk of disease and other illnesses and at universal and equal access to actions and services for its promotion, protection and recovery." Lei 8.080/1990 built the Unified Health System (SUS) as the named producer. Lei 12.401/2011 built CONITEC as the body that decides which technologies the SUS list will carry. Patients who were denied a drug sued anyway. Courts ordered the drug.
The number that is not a newspaper paraphrase sits in the Ministry of Health's own pharmaceutical account. Vieira's 2023 paper in Revista de Saúde Pública, using that account: in 2019, lawsuits consumed 25.2 percent of the Specialized Component of Pharmaceutical Care, 21 percent of it for ten medicines.
https://doi.org/10.11606/s1518-8787.2023057004579
CNJ president Barroso, opening Fonajus on 21 November 2024, put the court load at about 800,000 health cases pending as of September and 483,000 new that year, and said suits against private plans were more frequent than suits against the public system. Do not collapse those 800,000 into Article 196. The public-side fact is the 25.2 percent: a constitutional duty, a health system, a formulary, and a court that can still order what the formulary refused.
STF Theme 6 (RE 566.471, concluded September 2024; Binding Precedent 61) is the attempted repair. As a rule, a drug not on the SUS lists (Rename, Resme, Remume) cannot be ordered, regardless of cost. Six cumulative exceptions remain, and the plaintiff carries the proof. The Court is trying to put the claim back on the list. The apartments in France's DALO queue are the housing version of this; pointer only. Here the missing plant is a pharmacy, not a prefecture.